FIELD: pharmacology.
SUBSTANCE: agent containing belladonna alkaloids, tincture of European madder, magnesium salicylate, a mixture of essential oils with a set of active substances, salicylic acid, linoleic and linolenic acids, ethanol and castor oil is proposed, wherein the substance contains the sum of belladonna alkaloids, recalculated for hyoscyamine as belladonna alkaloids, eucalyptus essential oil, anise essential oil and fennel essential oil as essential oils, and 1,8-cineole eucalyptus essential oil as a biologically active substance with a certain content of the ingredients.
EFFECT: pronounced therapeutic effect in pain elimination and excretion of urinary stones, pronounced anti-inflammatory and diuretic effects.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG WITH LITHOLITHIC, DIURETIC AND ANTI-INFLAMMATORY ACTION | 2017 |
|
RU2635196C1 |
| ANTISPASMODIC, ANTIULCER AND ANTACID AGENT | 2021 |
|
RU2784057C1 |
| SPRAY FOR EMERGENCY PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2017 |
|
RU2665959C1 |
| AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
| COMPOSITION FOR TOPICAL APPLICATION IN THE TREATMENT OF ONYCHOMYCOSIS (OPTIONS) | 2022 |
|
RU2786851C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
| PHYTOMIXTURE WITH SEDATIVE EFFECT | 2013 |
|
RU2554796C2 |
